GlassScriptPhysician profile
Luis F Anez
NPI 1598741118
$6,296.58
in general payments reported to CMS, 2019-2025
38 companies · $571 in 2025
The $571 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $509 · 2020: $555 · 2021: $919 · 2022: $1,077 · 2023: $1,266 · 2024: $1,400 · 2025: $571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,236.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,907.15 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $525.55 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $434.01 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $401.10 | 2019-2024 | Rybelsus, Ozempic |
| Lilly USA, LLC | $290.92 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $273.29 | 2019-2025 | Vraylar, Synthroid |
| Merck Sharp & Dohme LLC | $265.12 | 2019-2024 | Verquvo, Steglatro |
| Abbott Laboratories | $254.53 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Pfizer INC. | $215.63 | 2019-2025 | |
| Amgen INC. | $197.32 | 2019-2025 | Otezla, Repatha, Otezla |
| Idorsia Pharmaceuticals US INC | $179.75 | 2022-2023 | Quviviq |
| Eisai INC. | $130.02 | 2020-2021 | |
| Cvrx, INC. | $125.91 | 2022 | |
| Hologic Sales and Service, LLC | $122.15 | 2024 | Thinprep 2000 Processor, Aptima |
| Lundbeck LLC | $111.99 | 2024-2025 | Rexulti |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Anez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.